Monopar Therapeutics (MNPR) Enterprise Value (QoQ) (2017 - 2025)
Monopar Therapeutics (MNPR) Enterprise Value (QoQ) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Monopar Therapeutics | 707.36 Mn | 645.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 51.57% |
| Sep 30, 2025 | -223.22% |
| Jun 30, 2025 | 0.53% |
| Mar 31, 2025 | 13.32% |
| Dec 31, 2024 | -661.06% |
| Sep 30, 2024 | 1.63% |
| Jun 30, 2024 | 21.62% |
| Mar 31, 2024 | -7.45% |
| Dec 31, 2023 | -31.74% |
| Sep 30, 2023 | 23.55% |
| Jun 30, 2023 | 30.78% |
| Mar 31, 2023 | -27.33% |
| Dec 31, 2022 | 41.21% |
| Sep 30, 2022 | 15.42% |
| Jun 30, 2022 | 7.61% |
| Mar 31, 2022 | 10.97% |
| Dec 31, 2021 | 8.96% |
| Sep 30, 2021 | 9.51% |
| Jun 30, 2021 | 5.56% |
| Mar 31, 2021 | -54.91% |